| 000 | 01814 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515181830.0 | ||
| 264 | 0 | _c20091207 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2009.155 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Luca, K | |
| 245 | 0 | 0 |
_aThe TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. _h[electronic resource] |
| 260 |
_bLeukemia _cNov 2009 |
||
| 300 |
_a2063-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
| 650 | 0 | 4 |
_aB-Lymphocytes _xcytology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Lineage _xdrug effects |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aFetal Blood _xcytology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipopeptides _xpharmacology |
| 650 | 0 | 4 |
_aLymphopoiesis _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMyeloid Cells _xcytology |
| 650 | 0 | 4 |
_aStromal Cells _xcytology |
| 650 | 0 | 4 |
_aToll-Like Receptor 1 _xagonists |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xagonists |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 700 | 1 | _aFrances-Duvert, V | |
| 700 | 1 | _aAsensio, M-J | |
| 700 | 1 | _aIhsani, R | |
| 700 | 1 | _aDebien, E | |
| 700 | 1 | _aTaillardet, M | |
| 700 | 1 | _aVerhoeyen, E | |
| 700 | 1 | _aBella, C | |
| 700 | 1 | _aLantheaume, S | |
| 700 | 1 | _aGenestier, L | |
| 700 | 1 | _aDefrance, T | |
| 773 | 0 |
_tLeukemia _gvol. 23 _gno. 11 _gp. 2063-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2009.155 _zAvailable from publisher's website |
| 999 |
_c19049196 _d19049196 |
||